Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share - Reconciliation of Net Loss (Details)

v3.21.1
Net Loss Per Share - Reconciliation of Net Loss (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net Loss Per Share    
Net loss $ (26,381,389) $ (20,384,716)
Net loss: Non-controlling interest (331,652) (367,148)
Net loss attributable to Heat Biologics, Inc. $ (26,049,737) $ (20,017,568)
Weighted Average Number of Shares Outstanding, Basic and Diluted 15,982,568 4,754,542
Net loss per share applicable to Heat Biologics, Inc - basic and diluted $ (1.63) $ (4.21)